NYSE:NVO News 27 June 2025

Game-Changing Vaccines, Breakthrough Drugs, and a CDC Shakeup: Biotech & Health News Roundup

In-Depth Report COVID-19 Vaccines and U.S. Public Health Upheaval Targeted Fall Boosters, But Access Tightened: U.S. health authorities approved new monovalent COVID-19 vaccines (by Pfizer–BioNTech, Moderna, and Novavax) updated for the 2025–26 season reuters.com. Unlike prior booster rollouts, the FDA

28 August 2025

Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights ([…Placeholder – if needed, otherwise this section can be omitted due to a lack of specific startup news on Aug 23–24 beyond the AI deal covered

24 August 2025

Biotech · Global Health · Healthcare · Investments · Medical Breakthroughs · NASDAQ:DVAX · NASDAQ:RCKT · NYSE:GSK · NYSE:NVO

Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Industry & Corporate Developments Mergers, Acquisitions & Partnerships Regulatory & Drug Approval Updates Public Health & Policy Research & Clinical Breakthroughs Sources: Reuters, Politico, HealthLeaders, BioPharma Dive, FierceBiotech, Pharmaceutical Executive, Technology Networks, McGill University reuters.com reuters.com healthleadersmedia.com reuters.com fiercebiotech.com reuters.com

21 August 2025

Biotech · Healthcare · Industry News · Medical Innovations · NASDAQ:CRL · NYSE:LLY · NYSE:MDT · NYSE:NVO · NYSE:PFE · NYSE:TAK · Pharmaceuticals

Tariff Tsunami, Tech Tumble & Peace Talk Buzz – Global Business Roundup (Aug 19–20, 2025)

Nvidia shares plunged on August 19, 2025, as part of a tech-led market selloff that dragged the Nasdaq about 1.5% lower. Futures priced in at least two 25-basis-point Fed rate cuts by year-end, while the U.S. 10-year yield eased to

20 August 2025

Economics · Global Business · International Relations · NASDAQ:GOOG · NASDAQ:INTC · NASDAQ:NVDA · NASDAQ:NXST · NASDAQ:TSLA · NYSE:LLY · NYSE:NVO · NYSE:TGNA · Technology · Trade

Biotech, Pharma, and Health Breakthroughs You Missed on August 17–18, 2025

New Drug Approvals & Clinical Trial Results Mergers, Acquisitions & Partnerships (No other major M&A deals were announced during Aug 17–18, but this Lilly-Superluminal alliance highlights the continued investment in AI-driven R&D.) Regulatory & Policy Updates Public Health & Epidemiology

18 August 2025

Biotech · Health · Medical News · NASDAQ:GBT · NASDAQ:MDGL · NASDAQ:TNXP · NYSE:NVO · NYSE:PFE · Pharma · Research

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy (semaglutide) received FDA accelerated approval to treat metabolic dysfunction-associated steatohepatitis (MASH), becoming the first GLP-1 therapy cleared for MASH in a patient population estimated at about 5% of U.S. adults, based on part 1 of an ongoing trial showing

16 August 2025

Biotechnology · Health News · Medical Innovations · Mergers & Acquisitions · NASDAQ:BNTX · NASDAQ:CVAC · NASDAQ:TNXP · NYSE:LLY · NYSE:NVO · NYSE:PFE · Pharmaceuticals

Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Original news reports, press releases and scientific publications from Aug 14–15, 2025 fda.gov fiercebiotech.com

15 August 2025

Biotech · Controversy · Global News · Health · Innovation · NASDAQ:PGEN · NASDAQ:PRLD · NYSE:NVO

All the Breakthroughs You Missed: The Biggest Science Stories from August 10–11, 2025

Medicine & Health Space & Astronomy Climate & Environment Physics & Materials Science Technology & Innovation Sources: The above summaries are based on reports and press releases from reputable outlets and journals, including The Guardian theguardian.com theguardian.com, Science sciencedaily.com sciencedaily.com,

11 August 2025

Breakthroughs · Discoveries · News · NYSE:NVO · Research · Science

Digital Health & Telemedicine Industry Update (June–July 2025)

In early June 2025, DispatchHealth and Medically Home completed a merger, forming one of the nation’s largest high-acuity hospital-at-home providers and operating under the DispatchHealth brand, integrating Medically Home’s virtual care technology and 24/7 clinical command centers. Teladoc Health signaled

3 July 2025

Digital Health · eHealth · Healthcare Technology · Industry Update · NASDAQ:MSFT · NYSE:HIMS · NYSE:NVO · NYSE:TDOC · Telemedicine

The State of Artificial Intelligence in 2025: Breakthroughs, Challenges, and the Road Ahead / Updated: 2025, July 1st, 12:02 CET

Meta launched Meta Superintelligence Labs (MSL), led by Alexandr Wang and Nat Friedman, unifying all AI R&D to accelerate AGI with a multi-billion-dollar investment reportedly over $70 billion and recruiting top talent from OpenAI, Anthropic, and Google. Microsoft unveiled the

1 July 2025

Artificial Intelligence · Future Predictions · Industry Insights · Innovation · NASDAQ:AAPL · NASDAQ:AMZN · NASDAQ:GOOGL · NASDAQ:GTLB · NASDAQ:META · NASDAQ:MSFT · NASDAQ:NVDA · NYSE:NVO · Technology Trends

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Late 2024, the first FDA-approved CRISPR-based therapy exagamglogene autotemcel (Casgevy) reached patients, with Vertex reporting $2 million in revenue from this sickle-cell gene-editing therapy in Q3 2024. Prime Medicine’s PM359 autologous CRISPR prime-edited cell therapy for chronic granulomatous disease began

27 June 2025

2025 Trends · Biotechnology · Forecast · Health Tech · Medical Innovation · NASDAQ:ABEO · NASDAQ:ITCI · NASDAQ:PRME · NASDAQ:RARE · NASDAQ:RGLS · NASDAQ:SWTX · NASDAQ:VRTX · NASDAQ:WVE · NYSE:AZN · NYSE:CTLT · NYSE:JNJ · NYSE:NVO · NYSE:NVS

NYSE:NVO News 27 June 2025 - 28 August 2025